Sector ratings Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-17 EDT			5-day change	1st Jan Change
515.55 ^USD	+1.94%		-1.60%	+13.72%

08-12	Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says	MT
08-11	Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
VERTEX PHARMACEUTICALS INCORPORATED	131B		AA
ELI LILLY AND COMPANY	1,055B		A
JOHNSON & JOHNSON	632B	-	BBB	-	-
ABBVIE INC.	442B		AA		-
ROCHE HOLDING AG	351B		AA
NOVARTIS AG	290B		AAA
ASTRAZENECA PLC	243B		A
AMGEN INC.	227B		A
NOVO NORDISK A/S	200B		A
GILEAD SCIENCES, INC.	172B		AA
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	132B		A
SANOFI	106B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.87B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.24B		AA
BAYER AG	54.51B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.66B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.49B		-
HALEON PLC	41.82B		AA
Average	227.6B		AA
Weighted average by Cap.			AA

×